Kikkawa Rie | Pfizer Global Research & Development Toxicology Nagoya Laboratoreis
スポンサーリンク
概要
関連著者
-
Kikkawa Rie
Worldwide Safety Sciences Pfizer Global Research And Development Nagoya Laboratories Pfizer Inc.
-
Kikkawa Rie
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Kikkawa Rie
Pfizer Global Research & Development Toxicology Nagoya Laboratoreis
-
Horii Ikuo
Showa Univ. (department Of Biochemical Toxicology School Of Pharmaceutical Sciences)
-
Horii I
Drug Safety Research And Development Pfizer Global Research And Development Nagoya Laboratories. Pfi
-
Horii Ikuo
Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Horii Ikuo
Worldwide Safety Sciences Pgrd Nagoya Laboratories Pfizer Inc.
-
Horii Ikuo
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Horii Ikuo
Biochemical Toxicology School Of Pharmaceutical Sciences Showa University
-
HORII Ikuo
Worldwide Safety Sciences, Nagoya Laboratories, Pfizer Global Research and Development, Pfizer Japan
-
KIKKAWA Rie
Worldwide Safety Sciences, Pfizer Global Research & Development, Nagoya Laboratories, Pfizer Inc.
-
Yamada Hiroshi
Drug Safety Research & Development Pfizer Global Research & Development Nagoya Laboratories
-
Horii Ikuo
Worldwide Safety Sciences
-
Yamamoto Toshinori
Drug Safety Research & Development Pfizer Global Research & Development Nagoya Laboratories
-
Yamamoto T
Showa Univ. Tokyo Jpn
-
Yamamoto Toshinori
Department Of Biochemical Toxicology School Of Pharmaceutical Sciences Showa University
-
YAMAMOTO Toshinori
Worldwide Safety Sciences, Pfizer Global Research & Development, Nagoya Laboratories, Pfizer Inc.
-
Yamamoto Toshinori
Departments Of Clinical Pharmacy And Pharmacognosy School Of Pharmaceutical Sciences Showa Universit
-
Yamamoto Toshinori
Department Of Pharmacology Medical College Of Oita
-
Yamada Hiroshi
Worldwide Safety Sciences Pfizer Global Research And Development Nagoya Laboratories Pfizer Japan In
-
Fukushima Tamio
Drug Safety Research And Development Nagoya Laboratories Pfizer Japan Inc.
-
Fukushima Tamio
Pfizer Global Research & Development Toxicology Nagoya Laboratoreis
-
Fukushima Tamio
Biochemical Toxicology School Of Pharmaceutical Sciences Showa University
-
Yamada Hiroshi
worldwide safety sciences
-
FUKUSHIMA Tamio
Worldwide Safety Sciences, Global Research & Development, Nagoya Laboratories, Pfizer Inc.
-
Fukushima Tamio
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Inc.
-
HAMADA Yoshimasa
Worldwide Safety Sciences, Pfizer Global Research and Development, Nagoya Laboratories, Pfizer Inc.
-
Hamada Yoshimasa
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Japan Inc.
-
Hamada Yoshimasa
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Fujikawa Masaaki
worldwide safety sciences
-
Mori C
Department Of Bioenvironmental Medicine Graduate School Of Medicine Chiba University
-
Mori Chisato
Department Of Bioenvironmental Medicine Graduate School Of Medicine Chiba University
-
Mori Chisato
千葉大学 医学研究院環境生命医学
-
Mori Chisato
Department Of Anatomy Faculty Of Medicine Kyoto University
-
Komiyama M
Department Of Bioenvironmental Medicine Graduate School Of Medicine Chiba University
-
Komiyama Masatoshi
Department Of Bioenvironmental Medicine:center For Environment Health And Field Sciences Chiba Unive
-
Moria Chisato
Department Of Bioenvironmental Medicine:environmental Health Science Project For Future Generations
-
Mori Chisato
Department Of Anatomy And Developmental Biology
-
Fujikawa Masaaki
Drug Safety Research & Development Pfizer Global Research & Development Nagoya Laboratories
-
Fujikawa Masaaki
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Japan
-
Komiyama Masatoshi
Department Of Bioenvironmental Medicine
-
Fujikawa Masaaki
Worldwide Safety Sciences Pfizer Global Research & Development Nagoya Laboratories Pfizer Japan
-
Fujikawa Masaaki
World Wide Safety Sciences
-
MORI Chisato
Deparment of Bioenvironmental Medicine, Graduate School of Medicine, Chiba University
-
HORII IKUO
Drug Safety Evaluation, Nagoya Laboratories, Pfizer Global Research and Development
-
FUKUSHIMA Tamio
Drug Safety Research and Development, Nagoya Laboratories, Pfizer Japan Inc.
-
HAMADA Yoshimasa
Drug Safety Research and Development, Nagoya Laboratories, Pfizer Japan Inc.
-
KIKKAWA Rie
Drug Safety Research & Development, Nagoya Laboratories, Pfizer Japan Inc.
-
KOMIYAMA Masatoshi
Department of Bioenvironmental Medline, Chiba Univ.
-
SHIOTANI Motohiro
Worldwide Safety Sciences, Pfizer Global Research and Development, Nagoya Laboratories, Pfizer Japan
-
Komiyama Masatoshi
Department Of Anatomy And Cell Biology School Of Medicine Chiba Unversity
-
Kato Masashi
Pfizer global research & development, Toxicology, Nagoya laboratoreis
-
Isogai Yumi
Pfizer global research & development, Toxicology, Nagoya laboratoreis
-
KIkkawa Rie
Pfizer global research & development, Toxicology, Nagoya laboratoreis
-
Hamada Yoshimasa
Pfizer global research & development, Toxicology, Nagoya laboratoreis
-
Horimoto Masao
Pfizer global research & development, Toxicology, Nagoya laboratoreis
-
Isogai Yumi
Pfizer Global Research & Development Toxicology Nagoya Laboratoreis
-
Horimoto Masao
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Hamada Y.
Drug Safety Research And Development Pfizer Global Research And Development Nagoya Laboratories. Pfi
-
Horii Ikuo
Drug Safety Evaluation Pfizer Global Research And Development
-
Shiotani Motohiro
Worldwide Safety Sciences Pfizer Global Research And Development Nagoya Laboratories Pfizer Japan In
-
Shiotani Motohiro
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Inc.
-
Horii Ikuo
Drug Safety Evaluation Global Research & Development Pfizer Inc.
-
Shitoni Motohiro
Worldwide Safety Sciences Global Research & Development Nagoya Laboratories Pfizer Japan Inc.
-
Hamada Yoshimasa
Drug Safety Research And Development Nagoya Laboratories Pfizer Japan Inc.
著作論文
- GENOMIC CLUSTER AND NETWORK ANALYSIS FOR PREDICTIVE SCREENING FOR HEPATOTOXICITY
- INVESTIGATION OF PROTEOMIC BIOMARKERS IN IN VIVO HEPATOTOXICITY STUDY OF RAT LIVER : TOXICITY DIFFERENTIATION IN HEPATOTOXICANTS
- IN VIVO HEPATOTOXICITY STUDY OF RATS IN COMPARISON WITH IN VITRO HEPATOTOXICITY SCREENING SYSTEM
- Investigation of protein expression induced by hepatotoxicants in rat hepatocytes cultures and livers(Proceedings of the 32nd Annual Meeting)
- Comparison between in vitro- and in vivo-hepatotoxicity for the investigation of a hepatotoxicity screening system in primary cell cultures(Liver, Alimentary system, Proceedings of the 32nd Annual Meeting)
- IDENTIFICATION OF OXIDATIVE STRESS-RELATED PROTEINS FOR PREDICTIVE SCREENING OF HEPATOTOXICITY USING A PROTEOMIC APPROACH
- EFFECTS OF MALE REPRODUCTIVE TOXICANTS ON GENE EXPRESSION IN RAT TESTES
- PROTEIN EXPRESSION ANALYSIS OF RAT TESTES INDUCED TESTICULAR TOXICITY WITH SEVERAL REPRODUCTIVE TOXICANTS
- INVESTIGATION OF A HEPATOTOXICITY SCREENING SYSTEM IN PRIMARY CELL CULTURES : WHAT BIOMARKERS WOULD NEED TO BE ADDRESSED TO ESTIMATE TOXICITY IN CONVENTIONAL AND NEW APPROACHES?
- Evaluation of the effects of Sulfasalazine, a male reproductive toxicant, on acrosome reaction in rat sperm.(GENERAL SESSION BY POSTER PRESENTATION)(DEVELOPMENT AND REPRODUCTION)
- P7-24 Investigation of the hepato-toxicity screening system in primary cell culture(IMMUNE AND ALLERGIC SYSTEM/KIDNEYS AND URINARY EXCRETION SYSTEM/CYTOTOXICITY/OTHERS-1)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- P6-46 Effect of reproductive toxicants on the protein expression in the rat testis(TOXICOGENOMICS)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- P6-45 Effect of reproductive toxicants on the gene expression in the testes of rats(TOXICOGENOMICS)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- Usefulness of Teflon sonde for oral administration in rats (TEST METHODS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)